(Q35149046)

6 August 2017

1 reference

title

New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system (English)

1 reference

6 August 2017

1 reference

Murielle Mimeault

1

1 reference

PubMed ID

12795332

6 August 2017

Nicole Pommery

series ordinal

2

1 reference

PubMed ID

12795332

6 August 2017

Jean-Pierre Hénichart

series ordinal

3

1 reference

6 August 2017

1 March 2003

1 reference

6 August 2017

Growth Factors Journal

1 reference

6 August 2017

21

1 reference

6 August 2017

1-14

1 reference

6 August 2017

1

1 reference

Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition

6 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

The caveolae membrane system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Androgen deprivation as a strategy for prostate cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

COX-2 and cancer: a new approach to an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Bcl-2 protein expression correlates with cell survival and androgen independence in rat prostatic lobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Growth factors and their receptors: new targets for prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Structure and function of sphingolipid- and cholesterol-rich membrane rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Androgen-mediated resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Distinct effects of ceramide-generating pathways in prostate adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Mitogenic action of LPA in prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

The development of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Ceramide induces cell death in the human prostatic carcinoma cell lines PC3 and DU145 but does not seem to be involved in Fas-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Emerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Mechanism of inhibition of Raf-1 by protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

The role of the androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Epidermal growth factor receptor biology (IMC-C225).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

The role of cyclooxygenase-2 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Mechanism of androgen receptor activation and possible implications for chemoprevention trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Nonandrogenic mediators of prostatic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Apoptosis: therapeutic significance in the treatment of androgen-dependent and androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Androgen and retinoic acid interaction in LNCaP cells, effects on cell proliferation and expression of retinoic acid receptors and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Growth inhibitory activity of lemnabourside on human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Differential effects of protein kinase A on Ras effector pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

New advances on structural and biological functions of ceramide in apoptotic/necrotic cell death and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

FTIR spectroscopic analyses of the temperature and pH influences on stratum corneum lipid phase behaviors and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Lipoxygenase inhibition in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Changes in biomarker expression in the development of prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Activation of the human androgen receptor through a protein kinase A signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

ZD1839 (Iressa): for more than just non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Prostate cancer: molecular biology of early progression to androgen independence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Human acid ceramidase is overexpressed but not mutated in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

CI-1033, a pan-erbB tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Growth factors: roles in andrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Targeting of epidermal growth factor receptor and protein kinase A: molecular basis and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Protein kinase A as target for novel integrated strategies of cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Sphingolipid transport: rafts and translocators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

A cellular striptease act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Essential role for G proteins in prostate cancer cell growth and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Eicosanoid regulation of angiogenesis in human prostate carcinoma and its therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0897719031000094921

10.1080/0897719031000094921

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12795332